Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Indomethacin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 known ✓ | P35354 | 10/20 | 0.75 |
| ▸ | PTGS1 known ✓ | P23219 | 3/20 | 0.75 |
| ▸ | AKR1C3 | P42330 | 7/20 | 0.75 |
| ▸ | AKR1C2 | P52895 | 6/20 | 0.75 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.75 |
| ▸ | AKR1C4 | P17516 | 2/20 | 0.75 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 0.75 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.75 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.75 |
| ▸ | LMNA | P02545 | 2/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.75 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.75 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.75 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.75 |
| ▸ | MEN1 | O00255 | 1/20 | 0.75 |
| ▸ | PTGES | O14684 | 1/20 | 0.75 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.75 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.75 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Indomethacin SCHEMBL356273 | 0.92 | PTGS2 (0.79) | PTGS2AKR1C3AKR1C2PTGS1HIF1A | |
| Indomethacin SCHEMBL11570993 | 0.92 | PTGS2 (0.79) | PTGS2AKR1C3AKR1C2PTGS1HIF1A | |
| Indomethacin SCHEMBL3518614 | 0.87 | PTGS2 (1.00) | PTGS2AKR1C3AKR1C2PTGS1HIF1A | |
| Indomethacin SCHEMBL29525957 | 0.87 | PTGS2 (1.00) | PTGS2AKR1C3AKR1C2PTGS1HIF1A | |
| Indomethacin SCHEMBL29353712 | 0.87 | PTGS2 (1.00) | PTGS2AKR1C3AKR1C2PTGS1HIF1A | |
| Indomethacin SCHEMBL9300 | 0.87 | PTGS2 (1.00) | PTGS2AKR1C3AKR1C2PTGS1HIF1A | |
| Indomethacin SCHEMBL23391006 | 0.86 | PTGS2 (0.98) | PTGS2AKR1C3AKR1C2PTGS1HIF1A | |
| Indomethacin SCHEMBL8352438 | 0.86 | PTGS2 (0.98) | PTGS2AKR1C3AKR1C2PTGS1HIF1A | |
| Indomethacin SCHEMBL1817813 | 0.86 | PTGS2 (0.98) | PTGS2AKR1C3AKR1C2PTGS1HIF1A | |
| Indomethacin SCHEMBL6554617 | 0.86 | PTGS2 (0.98) | PTGS2AKR1C3AKR1C2PTGS1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1104296-B1 | BIOIMPLANT FORMULATION | PEPTECH ANIMAL HEALTH PTY LTD (AU) | 2012-06-13 | — | — | EP | claimed |
| CN-1243543-C | Biological implant formulation | PEPTECH LTD (AU) | 2006-03-01 | — | — | CN | claimed |
| US-6913761-B1 | Bioimplant formulation | PEPTECH LIMITED (AU) | 2005-07-05 | — | — | US | claimed |
| EP-1104296-A4 | BIOIMPLANT FORMULATION | PEPTECH LTD (AU) | 2004-11-10 | — | — | EP | claimed |
| CN-1310623-A | Biological implant formulation | PEPTECH LTD (AU) | 2001-08-29 | — | — | CN | claimed |
| EP-1104296-A1 | BIOIMPLANT FORMULATION | PEPTECH LIMITED (AU) | 2001-06-06 | — | — | EP | claimed |
| WO-2000004897-A1 | BIOIMPLANT FORMULATION | PEPTECH LIMITED (AU) | 2000-02-03 | — | — | WO | claimed |
| EP-1104296-B1 | BIOIMPLANT FORMULATION | PEPTECH ANIMAL HEALTH PTY LTD (AU) | 2012-06-13 | — | — | EP | disclosed |
| US-8052982-B2 | Bioimplant formulation comprising lecithin and stearin | PEPTECH ANIMAL HEALTH PTY LIMITED (AU) | 2011-11-08 | — | — | US | disclosed |
| US-20080031956-A1 | Bioimplant formulation | PEPTECH LIMITED (AU) | 2008-02-07 | — | — | US | disclosed |
| CN-1243543-C | Biological implant formulation | PEPTECH LTD (AU) | 2006-03-01 | — | — | CN | disclosed |
| CN-1736487-A | Bioimplant formulation | PEPTECH LTD (AU) | 2006-02-22 | — | — | CN | disclosed |
| US-20050276854-A1 | Bioimplant formulation | PEPTECH LIMITED (AU) | 2005-12-15 | — | — | US | disclosed |
| US-6913761-B1 | Bioimplant formulation | PEPTECH LIMITED (AU) | 2005-07-05 | — | — | US | disclosed |
| EP-1104296-A4 | BIOIMPLANT FORMULATION | PEPTECH LTD (AU) | 2004-11-10 | — | — | EP | disclosed |
| CN-1310623-A | Biological implant formulation | PEPTECH LTD (AU) | 2001-08-29 | — | — | CN | disclosed |
| EP-1104296-A1 | BIOIMPLANT FORMULATION | PEPTECH LIMITED (AU) | 2001-06-06 | — | — | EP | disclosed |
| WO-2000004897-A1 | BIOIMPLANT FORMULATION | PEPTECH LIMITED (AU) | 2000-02-03 | — | — | WO | disclosed |